TCT-573 Characterization of edge effects with second-generation drug-eluting absorbable metal scaffold assessed by optical coherence tomography, intravascular ultrasound grayscale, and virtual histology at 6- and 12-month. A Biosolve II substudy
2017 ◽
Vol 70
(18)
◽
pp. B237
2019 ◽
Vol 20
(5)
◽
pp. 392-398
◽
2014 ◽
Vol 15
(3)
◽
pp. 149-155
◽
2013 ◽
Vol 35
(12)
◽
pp. 795-807
◽
Keyword(s):